447 related articles for article (PubMed ID: 15027860)
21. Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
Ahmad I; Filep JJ; Franklin JC; Janoff AS; Masters GR; Pattassery J; Peters A; Schupsky JJ; Zha Y; Mayhew E
Cancer Res; 1997 May; 57(10):1915-21. PubMed ID: 9157985
[TBL] [Abstract][Full Text] [Related]
22. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
Andresen TL; Jensen SS; Jørgensen K
Prog Lipid Res; 2005 Jan; 44(1):68-97. PubMed ID: 15748655
[TBL] [Abstract][Full Text] [Related]
23. Enzymatic action of phospholipase A₂ on liposomal drug delivery systems.
Hansen AH; Mouritsen OG; Arouri A
Int J Pharm; 2015 Aug; 491(1-2):49-57. PubMed ID: 26056930
[TBL] [Abstract][Full Text] [Related]
24. Biomimetic nanoassemblies of 1-O-octodecyl-2-conjugated linoleoyl-sn-glycero-3-phosphatidyl gemcitabine with phospholipase A
Zuo J; Tong L; Du L; Yang M; Jin Y
Colloids Surf B Biointerfaces; 2017 Apr; 152():467-474. PubMed ID: 28187380
[TBL] [Abstract][Full Text] [Related]
25. Drug-phospholipid conjugates as potential prodrugs: synthesis, characterization, and degradation by pancreatic phospholipase A(2).
Kurz M; Scriba GK
Chem Phys Lipids; 2000 Oct; 107(2):143-57. PubMed ID: 11090844
[TBL] [Abstract][Full Text] [Related]
26. Calcein permeation across phosphatidylcholine bilayer membrane: effects of membrane fluidity, liposome size, and immobilization.
Shimanouchi T; Ishii H; Yoshimoto N; Umakoshi H; Kuboi R
Colloids Surf B Biointerfaces; 2009 Oct; 73(1):156-60. PubMed ID: 19560324
[TBL] [Abstract][Full Text] [Related]
27. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes.
Li WM; Xue L; Mayer LD; Bally MB
Biochim Biophys Acta; 2001 Aug; 1513(2):193-206. PubMed ID: 11470091
[TBL] [Abstract][Full Text] [Related]
28. The interdigitated gel phase in mixtures of cationic and zwitterionic phospholipids.
Smith EA; Dea PK
Biophys Chem; 2015 Jan; 196():86-91. PubMed ID: 25451682
[TBL] [Abstract][Full Text] [Related]
29. Surface-active properties of the antitumour ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (edelfosine).
Busto JV; Sot J; Goñi FM; Mollinedo F; Alonso A
Biochim Biophys Acta; 2007 Jul; 1768(7):1855-60. PubMed ID: 17543274
[TBL] [Abstract][Full Text] [Related]
30. Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer.
Liang X; Gao J; Jiang L; Luo J; Jing L; Li X; Jin Y; Dai Z
ACS Nano; 2015 Feb; 9(2):1280-93. PubMed ID: 25599568
[TBL] [Abstract][Full Text] [Related]
31. Small angle X-ray scattering (SAXS) and differential scanning calorimetry (DSC) studies of amide phospholipids.
Zhai X; Bartel M; Brezesinski G; Rattay B; Möhwald H; Li J
Chem Phys Lipids; 2005 Jan; 133(1):79-88. PubMed ID: 15589228
[TBL] [Abstract][Full Text] [Related]
32. [Inhibition of phospholipase A2 of peritoneal macrophages in rats by 1,2-di-O-hexadecyl-rac-glycero-3-phosphocholine].
Boucrot P; Khettab EN; Petit JY; Welin L
C R Acad Sci III; 1993; 316(3):169-76. PubMed ID: 8364761
[TBL] [Abstract][Full Text] [Related]
33. Surface charge modulation of liposomes by enzymatic hydrolysis of macrocyclic 1,2-dotriacontanedioyl-sn-glycero-3-phosphocholine.
Yamauchi K; Yamamoto I; Kinoshita M
Biochim Biophys Acta; 1988 Feb; 938(1):51-60. PubMed ID: 3337817
[TBL] [Abstract][Full Text] [Related]
34. Parameterization of the CHARMM All-Atom Force Field for Ether Lipids and Model Linear Ethers.
Leonard AN; Pastor RW; Klauda JB
J Phys Chem B; 2018 Jul; 122(26):6744-6754. PubMed ID: 29870257
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug.
Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Keefe KS; Wiley CA; Freeman WR
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1487-95. PubMed ID: 10359331
[TBL] [Abstract][Full Text] [Related]
36. Effect of fatty acids on the permeability barrier of model and biological membranes.
Arouri A; Lauritsen KE; Nielsen HL; Mouritsen OG
Chem Phys Lipids; 2016 Oct; 200():139-146. PubMed ID: 27725161
[TBL] [Abstract][Full Text] [Related]
37. Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.
Boakye CH; Patel K; Singh M
Int J Pharm; 2015 Jul; 489(1-2):106-16. PubMed ID: 25910414
[TBL] [Abstract][Full Text] [Related]
38. Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2.
Andresen TL; Jensen SS; Kaasgaard T; Jørgensen K
Curr Drug Deliv; 2005 Oct; 2(4):353-62. PubMed ID: 16305438
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and properties of dimeric glycerophospholipid: 2,2'-dotriacontanedioylbis(1-palmitoyl-sn-glycero-3-phosphocholine).
Yamauchi K; Togawa K; Kinoshita M
J Biochem; 1996 Jan; 119(1):115-9. PubMed ID: 8907184
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic study of the sPLA2-mediated hydrolysis of a thio-ester pro anticancer ether lipid.
Linderoth L; Fristrup P; Hansen M; Melander F; Madsen R; Andresen TL; Peters GH
J Am Chem Soc; 2009 Sep; 131(34):12193-200. PubMed ID: 19663381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
